Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro.
Cullia G, Bruno S, Parapini S, Margiotta M, Tamborini L, Pinto A, Galbiati A, Mozzarelli A, Persico M, Paladino A, Fattorusso C, Taramelli D, Conti P. Cullia G, et al. Among authors: pinto a. ACS Med Chem Lett. 2019 Feb 20;10(4):590-595. doi: 10.1021/acsmedchemlett.8b00592. eCollection 2019 Apr 11. ACS Med Chem Lett. 2019. PMID: 30996801 Free PMC article.
Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
Conti P, De Amici M, Grazioso G, Roda G, Pinto A, Hansen KB, Nielsen B, Madsen U, Bräuner-Osborne H, Egebjerg J, Vestri V, Pellegrini-Giampietro DE, Sibille P, Acher FC, De Micheli C. Conti P, et al. Among authors: pinto a. J Med Chem. 2005 Oct 6;48(20):6315-25. doi: 10.1021/jm0504499. J Med Chem. 2005. PMID: 16190758
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake.
Colleoni S, Jensen AA, Landucci E, Fumagalli E, Conti P, Pinto A, De Amici M, Pellegrini-Giampietro DE, De Micheli C, Mennini T, Gobbi M. Colleoni S, et al. Among authors: pinto a. J Pharmacol Exp Ther. 2008 Aug;326(2):646-56. doi: 10.1124/jpet.107.135251. Epub 2008 May 1. J Pharmacol Exp Ther. 2008. PMID: 18451317
Design and synthesis of novel isoxazole-based HDAC inhibitors.
Conti P, Tamborini L, Pinto A, Sola L, Ettari R, Mercurio C, De Micheli C. Conti P, et al. Among authors: pinto a. Eur J Med Chem. 2010 Sep;45(9):4331-8. doi: 10.1016/j.ejmech.2010.06.035. Epub 2010 Jun 30. Eur J Med Chem. 2010. PMID: 20637529
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
Conti P, Pinto A, Tamborini L, Madsen U, Nielsen B, Bräuner-Osborne H, Hansen KB, Landucci E, Pellegrini-Giampietro DE, De Sarro G, Donato Di Paola E, De Micheli C. Conti P, et al. Among authors: pinto a. ChemMedChem. 2010 Sep 3;5(9):1465-75. doi: 10.1002/cmdc.201000184. ChemMedChem. 2010. PMID: 20665761
4,653 results